Atlas Trials

A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer

Clinical trial NCT06944587 · RECRUITING

Trial details

NCT number
NCT06944587
Sponsor
Oslo University Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Locally Advanced Pancreatic CancerBorderline Resectable Pancreatic CancerPancreatectomyChemotherapy Effect
Start date
2024-12-03
Primary completion
2028-12-31
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.